Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site
dc.contributor.author | Angulo, Jenniffer | |
dc.contributor.author | Caceres, C. Joaquin | |
dc.contributor.author | Contreras, Nataly | |
dc.contributor.author | Fernandez-Garcia, Leandro | |
dc.contributor.author | Chamond, Nathalie | |
dc.contributor.author | Ameur, Melissa | |
dc.contributor.author | Sargueil, Bruno | |
dc.contributor.author | Lopez-Lastra, Marcelo | |
dc.date.accessioned | 2025-01-20T20:18:05Z | |
dc.date.available | 2025-01-20T20:18:05Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Translation initiation of the hepatitis C virus (HCV) mRNA depends on an internal ribosome entry site (IRES) that encompasses most of the 5 ' UTR and includes nucleotides of the core coding region. This study shows that the polypyrimidine-tract-binding protein (PTB), an RNA-binding protein with four RNA recognition motifs (RRMs), binds to the HCV 5 ' UTR, stimulating its IRES activity. There are three isoforms of PTB: PTB1, PTB2, and PTB4. Our results show that PTB1 and PTB4, but not PTB2, stimulate HCV IRES activity in HuH-7 and HEK293T cells. In HuH-7 cells, PTB1 promotes HCV IRES-mediated initiation more strongly than PTB4. Mutations in PTB1, PTB4, RRM1/RRM2, or RRM3/RRM4, which disrupt the RRM's ability to bind RNA, abrogated the protein's capacity to stimulate HCV IRES activity in HuH-7 cells. In HEK293T cells, PTB1 and PTB4 stimulate HCV IRES activity to similar levels. In HEK293T cells, mutations in RRM1/RRM2 did not impact PTB1 ' s ability to promote HCV IRES activity; and mutations in PTB1 RRM3/RRM4 domains reduced, but did not abolish, the protein's capacity to stimulate HCV IRES activity. In HEK293T cells, mutations in PTB4 RRM1/RRM2 abrogated the protein's ability to promote HCV IRES activity, and mutations in RRM3/RRM4 have no impact on PTB4 ability to enhance HCV IRES activity. Therefore, PTB1 and PTB4 differentially stimulate the IRES activity in a cell type-specific manner. We conclude that PTB1 and PTB4, but not PTB2, act as IRES transacting factors of the HCV IRES. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.3390/v15010008 | |
dc.identifier.eissn | 1999-4915 | |
dc.identifier.uri | https://doi.org/10.3390/v15010008 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/92440 | |
dc.identifier.wosid | WOS:000927749500001 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.revista | Viruses-basel | |
dc.rights | acceso restringido | |
dc.subject | HCV | |
dc.subject | IRES | |
dc.subject | PTB | |
dc.subject | ITAF | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site | |
dc.type | artículo | |
dc.volumen | 15 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |